RETATURIDE 10 MG
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple mechanism delivers superior appetite suppression, enhanced fat oxidation, and improved glucose regulation compared to single or dual receptor agonists, positioning Retatrutide at the cutting edge of metabolic pharmacology.
Clinical trial data has demonstrated unprecedented levels of fat mass reduction with Retatrutide, with outcomes that surpass those seen with tirzepatide or semaglutide. Its glucagon component adds an additional fat-burning and energy-expenditure dimension that is absent in GLP-1-only compounds, making it particularly effective for stubborn or visceral fat reduction.
Retatrutide is gaining significant attention among performance athletes and those seeking aggressive body recomposition. It is intended for use under qualified medical supervision as part of a structured nutrition and lifestyle program, and represents one of the most powerful pharmacological tools currently being studied for metabolic health and body composition management.
| Details | Information |
|---|---|
| API | Retatrutide |
| Strength | 10 MG |
| Format | Lyophilised Peptide Vial |
| Category | Fat Loss / Metabolic |
| Usage | Injectable — Reconstitute before use |
Disclaimer: Above mentioned information is for educational and reference purposes only. Consult a registered healthcare professional for a proper course of medication. These statements have not been evaluated by the Food and Drug Administration. This product shall only be available on a prescription from a registered healthcare professional.
Frequently Asked Questions
What is RETATURIDE?
What is RETATURIDE commonly associated with?
How is RETATURIDE typically used?
Are there risks associated with RETATURIDE?
Can RETATURIDE be used without medical supervision?
Is RETATURIDE suitable for everyone?







Reviews
There are no reviews yet.